Grassley Against Int’l Price Index But Holds Tongue Until Formal Proposal

January 10, 2019
Senate Finance Committee Chair Chuck Grassley (R-IA) said he is waiting to see what CMS formally proposes before passing judgment on the International Pricing Index demonstration, but he nevertheless opposes the most important aspect of the informal proposal: indexing U.S. drug prices to those set by foreign countries. The administration proposed on Oct. 25 to test what it calls the International Pricing Index model, which would base doctor reimbursement for administering drugs in part on drug prices set by foreign...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.